Global Next-Generation Biomanufacturing Market

Report ID : 1261 | Published : 2022-06-13 | Pages: 167 | Format: PDF/EXCEL

The global Next-Generation Biomanufacturing Market size was accounted at USD 19.85 Bn in 2021; It is projected to grow at a compound annual growth rate (CAGR) of 9.3% from 2022 to 2030. Biomanufacturing is the production process of biomolecules by utilizing biological services to use in medical & industrial applications. Next-generation biomanufacturing products provide superior services in terms of quality and efficiency compared to first-generation biomanufacturing products.

Major driving factors of the next-generation biomanufacturing market are rising government funding for the development of modern bioprocessing technologies, rapid adoption of advanced technologies, increasing investments by pharma companies to develop & adopt next-generation biomanufacturing products, growing patient population, and increasing awareness among the people regarding the benefits of next-generation biomanufacturing. With the growing demand for drugs and therapies, many biopharmaceutical companies prefer adopting next-generation biomanufacturing services to balance the process design, performance, & efficiency with time and cost. This development is estimated to propel the market growth opportunities over the forecast years. However, complex manufacturing and development procedures and a lack of specialized expertise may hinder the market growth during the estimated timeframe.

The next-generation biomanufacturing market is segmented into medical applications, products, workflow, end-users, and regions. The medical applications segment comprises monoclonal antibodies, hormones, vaccines, recombinant proteins, and other applications. Due to their increasing medical applications, the monoclonal antibodies segment will dominate this market during the forecast years. Based on the products, the market is divided into continuous upstream biomanufacturing products, single-use upstream biomanufacturing products, and downstream biomanufacturing products. The market is classified into upstream and downstream biomanufacturing based on workflow. By end-users, the market is segmented into biopharmaceutical companies, CMOs (contract manufacturing organizations)/CDMOs (contract development and manufacturing organization), and research institutions. Biopharmaceutical companies are estimated to hold a significant market share in the coming years owing to the growing prevalence of chronic diseases and the high demand for protein/drug production. Region-wise, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

North America led the market due to the robust presence of large biopharmaceutical businesses, the improved infrastructure in biological research, and the rising usage of innovative technologies. The Asia-Pacific market is expected to witness the fastest growth during the forecast period due to the rapid adoption of advanced technologies, rising patient pool, and the high prevalence of chronic diseases. Apart from this, Europe holds the second position in this market regarding revenue share.

Some of the key players operating in the next-generation biomanufacturing market are Applikon Biotechnology BV (Netherlands), bbi-biotech GmbH (Germany), Danaher Corporation (US), Eppendorf AG (Germany), Esco Group of Companies (US), GEA Group Aktiengesellschaft (Germany), Meissner Filtration Products, Inc. (US), Merck KGaA (Germany), PBS Biotech, Inc. (US), Pierre Guérin (France), Sartorius AG (Germany), Shanghai Bailun Biotechnology Co. Ltd. (China), Solaris Biotechnology Srl. (Italy), Thermo Fisher Scientific Inc. (US), ZETA GmbH (Austria), and other.

Chapter 1. Methodology and Scope

1.1.        Research Methodology

1.2.        Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Next-Generation Biomanufacturing Market Snapshot

Chapter 4. Global Next-Generation Biomanufacturing Market Variables, Trends & Scope

4.1.        Market Segmentation & Scope

4.2.        Drivers

4.3.        Challenges

4.4.        Trends

4.5.        Investment and Funding Analysis

4.6.        Industry Analysis – Porter’s Five Forces Analysis

4.7.        Competitive Landscape & Market Share Analysis

4.8.        Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Medical Applications, Estimates & Trend Analysis

5.1.        By Medical Applications, & Market Share, 2020 & 2030

5.2.        Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Medical Applications:

5.2.1.     Monoclonal Antibodies

5.2.2.     Hormones

5.2.3.     Vaccines

5.2.4.     Recombinant Proteins

5.2.5.     Other Applications

Chapter 6. Market Segmentation 2: By Products Estimates & Trend Analysis

6.1.        By Products & Market Share, 2020 & 2030

6.2.        Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Products:

6.2.1.     Continuous Upstream Biomanufacturing Products

6.2.2.     Single-Use Upstream Biomanufacturing Products

6.2.3.     Downstream Biomanufacturing Products

Chapter 7. Market Segmentation 3: By Workflow Estimates & Trend Analysis

7.1.        By Workflow & Market Share, 2020& 2030

7.2.        Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Workflow:

7.2.1.     Upstream Biomanufacturing

7.2.2.     Downstream Biomanufacturing

Chapter 8. Market Segmentation 4: By End-Users Estimates & Trend Analysis

8.1.        By End-Users & Market Share, 2020& 2030

8.2.        Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-Users

8.2.1.     Biopharmaceutical Companies

8.2.2.     CMOs/CDMOs

8.2.3.     Research Institutions

Chapter 9. Next-Generation Biomanufacturing Market Segmentation 5: Regional Estimates & Trend Analysis

9.1.        North America

9.1.1.     North America Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts By Medical Applications, 2019-2030

9.1.2.     North America Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts By Products, 2019-2030

9.1.3.     North America Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts By Workflow, 2019-2030

9.1.4.     North America Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts by End-Users, 2019-2030

9.1.5.     North America Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts by country, 2019-2030

9.2.        Europe

9.2.1.     Europe Next-Generation Biomanufacturing Market revenue (US$ Million) By Medical Applications, 2019-2030

9.2.2.     Europe Next-Generation Biomanufacturing Market revenue (US$ Million) By Products, 2019-2030

9.2.3.     Europe Next-Generation Biomanufacturing Market revenue (US$ Million) By Workflow, 2019-2030

9.2.4.     Europe Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts by End-Users, 2019-2030

9.2.5.     Europe Next-Generation Biomanufacturing Market revenue (US$ Million) by country, 2019-2030

9.3.        Asia Pacific

9.3.1.     Asia Pacific Next-Generation Biomanufacturing Market revenue (US$ Million) By Medical Applications, 2019-2030

9.3.2.     Asia Pacific Next-Generation Biomanufacturing Market revenue (US$ Million) By Products, 2019-2030

9.3.3.     Asia Pacific Next-Generation Biomanufacturing Market revenue (US$ Million) By Workflow, 2019-2030

9.3.4.     Asia Pacific Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts by End-Users, 2019-2030

9.3.5.     Asia Pacific Next-Generation Biomanufacturing Market revenue (US$ Million) by country, 2019-2030

9.4.        Latin America

9.4.1.     Latin America Next-Generation Biomanufacturing Market revenue (US$ Million) By Medical Applications, (US$ Million) 2019-2030

9.4.2.     Latin America Next-Generation Biomanufacturing Market revenue (US$ Million) By Products, (US$ Million) 2019-2030

9.4.3.     Latin America Next-Generation Biomanufacturing Market revenue (US$ Million) By Workflow, (US$ Million) 2019-2030

9.4.4.     Latin America Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts by End-Users, 2019-2030

9.4.5.     Latin America Next-Generation Biomanufacturing Market revenue (US$ Million) by country, 2019-2030

9.5.        Middle East & Africa

9.5.1.     Middle East & Africa Next-Generation Biomanufacturing Market revenue (US$ Million) By Medical Applications, (US$ Million) 2019-2030

9.5.2.     Middle East & Africa Next-Generation Biomanufacturing Market revenue (US$ Million) By Products, (US$ Million) 2019-2030

9.5.3.     Middle East & Africa Next-Generation Biomanufacturing Market revenue (US$ Million) By Workflow, (US$ Million) 2019-2030

9.5.4.     Middle East & Africa Next-Generation Biomanufacturing Market revenue (US$ Million) estimates and forecasts by End-Users, 2019-2030

9.5.5.     Middle East & Africa Next-Generation Biomanufacturing Market revenue (US$ Million) by country, 2019-2030

 

Chapter 10. Competitive Landscape

10.1.      Major Mergers and Acquisitions/Strategic Alliances

10.2.      Company Profiles

 

10.2.1.  Applikon Biotechnology BV

10.2.2.  bbi-biotech GmbH

10.2.3.  Danaher Corporation

10.2.4.  Eppendorf AG

10.2.5.  Esco Group of Companies

10.2.6.  GEA Group Aktiengesellschaft

10.2.7.  Meissner Filtration Products, Inc.

10.2.8.  Merck KGaA

10.2.9.  PBS Biotech, Inc.

10.2.10. Pierre Guérin

10.2.11. Sartorius AG

10.2.12. Shanghai Bailun Biotechnology Co. Ltd.

10.2.13. Solaris Biotechnology Srl.

10.2.14. Thermo Fisher Scientific Inc.

10.2.15. ZETA GmbH

10.2.16. Other Prominent Players

 Market Segmentation

Global Next-Generation Biomanufacturing Market, by Medical Applications, 2020-2030 (Value US$ Mn)

  • Monoclonal Antibodies
  • Hormones
  • Vaccines
  • Recombinant Proteins
  • Other Applications

Global Next-Generation Biomanufacturing Market, by Products, 2020-2030 (Value US$ Mn)

  • Continuous Upstream Biomanufacturing Products
  • Single-Use Upstream Biomanufacturing Products
  • Downstream Biomanufacturing Products

Global Next-Generation Biomanufacturing Market, by Workflow, 2020-2030 (Value US$ Mn)

  • Upstream Biomanufacturing
  • Downstream Biomanufacturing

Global Next-Generation Biomanufacturing Market, by End-Users, 2020-2030 (Value US$ Mn)

  • Biopharmaceutical Companies
  • CMOs (Contract manufacturing organizations)/CDMOs (Contract Development and Manufacturing Organization)
  • Research Institutions

Global Next-Generation Biomanufacturing Market, by Region, 2020-2030 (Value US$ Mn)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Next-Generation Biomanufacturing Market, by Country, 2020-2030 (Value US$ Mn)

  • U.S.
  • Canada

Europe Next-Generation Biomanufacturing Market, by Country, 2020-2030 (Value US$ Mn)

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Next-Generation Biomanufacturing Market, by Country, 2020-2030 (Value US$ Mn)

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Next-Generation Biomanufacturing Market, by Country, 2020-2030 (Value US$ Mn)

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Next-Generation Biomanufacturing Market, by Country, 2020-2030 (Value US$ Mn)

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients